/
/
/

Valiant Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
₹115 Cr₹92 Cr₹52 Cr₹46 Cr₹47 Cr₹58 Cr₹35 Cr₹21 Cr₹19 Cr₹31 Cr₹41 Cr₹60 Cr₹51 Cr₹90 Cr₹71 Cr₹88 Cr
₹86 L₹17 L₹63 L₹87 L₹66 L-₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹78 L₹1 Cr
₹116 Cr₹92 Cr₹53 Cr₹47 Cr₹47 Cr₹55 Cr₹37 Cr₹25 Cr₹22 Cr₹33 Cr₹42 Cr₹63 Cr₹54 Cr₹92 Cr₹72 Cr₹89 Cr
₹89 Cr₹90 Cr₹55 Cr₹47 Cr₹45 Cr₹54 Cr₹35 Cr₹29 Cr₹22 Cr₹36 Cr₹47 Cr₹61 Cr₹48 Cr₹82 Cr₹61 Cr₹78 Cr
₹30 Cr₹5 Cr-₹26 L₹95 L₹3 Cr₹2 Cr₹2 Cr-₹3 Cr₹43 L-₹2 Cr-₹5 Cr₹2 Cr₹6 Cr₹10 Cr₹11 Cr₹12 Cr
₹1 Cr₹1 Cr₹68 L₹14 L₹7 L₹6 L₹6 L₹60,000₹5 L₹2 L₹2 L₹2 L₹2 L₹3 L₹4 L₹17 L
₹26 Cr₹1 Cr-₹3 Cr₹28 L₹2 Cr₹94 L₹2 Cr-₹4 Cr-₹16 L-₹3 Cr-₹5 Cr₹1 Cr₹6 Cr₹10 Cr₹10 Cr₹12 Cr
₹21 Cr₹2 Cr-₹7 Cr₹20 L₹2 Cr₹70 L₹2 Cr-₹5 Cr-₹51 L-₹1 Cr-₹4 Cr₹79 L₹4 Cr₹8 Cr₹8 Cr₹9 Cr

Share Price Live Stats

Open (₹)123.15
Volume (₹)62,693.00
High (₹)126.50
Upper Circuit129.30
Low (₹)119.52
Lower Circuit117.00
Prev Close123.15
52W High (₹)132.25
Price124.87
52W Low (₹)49.51

Share Market Cap & Key Ratios Overview

M.Cap (₹)666.36 Cr
Div. Yield (%)0.00
PE Ratio41.63
Debt to Equity0.52
Price to Book1.42
Book Value50.05
EPS (TTM)2.95
Face Value10.00
ROE (%)-0.93

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
VALIANTLAB-BENSE
LTP
1W Low
1W High
Market cap (₹)
1852.2+14.9 (0.81%)
1832.20
1891.50
4,44,597Cr
9619.5+244.5 (2.61%)
9312.50
9740
2,55,195Cr
4988.5+148.5 (3.07%)
4848.50
5010
1,87,712Cr
1203.9+43.9 (3.78%)
1152.10
1208.60
1,17,705Cr
1399.7+5.2 (0.37%)
1364.50
1421
1,13,423Cr
2007+53 (2.71%)
1963.80
2055.30
1,09,481Cr
2474.9+174.2 (7.57%)
2303
2504.60
1,02,229Cr
1201+16 (1.35%)
1185
1222
1,00,195Cr
1712-22 (-1.27%)
1689.30
1740
98,965Cr
2092+9 (0.43%)
2077.50
2135
95,939Cr
124.87+1.61 (1.31%)
117.30
132.25
666Cr

Key Highlights of Valiant Laboratories Ltd’s P&L

In 2025-03-31, Valiant Laboratories Ltd reported total revenue of ₹138.83Cr, compared with ₹191.74Cr in 2024-03-31, reflecting Valiant Laboratories Ltd turnover.

Depreciation was ₹2.09Cr and finance costs were ₹17.53Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹-₹1.51Cr in 2025-03-31 as compared to ₹-₹76.95Lakh in 2024-03-31.

Net Profit (PAT) was ₹-₹2.2Cr in 2025-03-31 compared with ₹31.96Lakh in 2024-03-31.

Earnings per share (EPS) were ₹-0.51 in 2025-03-31, compared with ₹0.07 in 2024-03-31.